Granulocyte-macrophage colony-stimulating factor and interferon-γ prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae

Medical Mycology

Volumn 34, Issue 1, 1996, Pages 63-69

  Roilides, E ^a   Blake, C ^a   Holmes, A ^b   Pizzo, P A ^a   Walsh, T J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; NONHUMAN;

ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DEXAMETHASONE; GLUCOCORTICOIDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSION; INTERFERON TYPE II; MONOCYTES; SUPEROXIDES;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS FURNIGATUS;

EID: 79961159101     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/02681219680000101     Document Type: Article

References (42)

1. Walsh TJ. Invasive aspergillosis in patients with neoplastic diseases. Semin Resp Infect 1990; 5: 111-22. (Pubitemid 20310296)
2. Graham BS, Tucker WS. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984; 101: 334-8. (Pubitemid 14033781)
3. Walsh TJ, Mendelsohn G. Invasive aspergillosis complicating Cushing's syndrome. Arch Intern Med 1981; 141: 1227-8. (Pubitemid 11017512)
4. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347-53. (Pubitemid 16215250)
5. Diamond RD, Krzesick R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol 1978; 91: 313-28. (Pubitemid 8334888)
6. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorpho-nuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Cin Invest 1982; 69: 617-31. (Pubitemid 12184959)
7. Diamond RD, Huber E, Haudenschild CC. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. J Infect Dis 1983; 147: 474-83. (Pubitemid 13163187)
8. Bowen DL, Fauci AS. Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R, (eds), Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1988: 877-95.
9. Lehmeyer JE, Johnston RB. Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol 1978; 9: 482-90. (Pubitemid 8296180)
10. Szefler SJ, Norton CE, Ball B, et al. IFN-gamma and LPS overcome glucocortcod inhibition of priming for superoxide release in human monocytes. J Immunol 1989; 142: 3985-92.
11. DiRosa M, Radomski M, Carnuccio R, Moncada S. Gluco-corticoids inhibit the induction of nitric oxide in macrophages. Biochem Biophys Res Commun 1990; 172: 1246-52.
12. Rinehart JJ, Balcerzak SP, Sagone AL, LoBuglio AF. Effects of corticosteroids on human monocyte function. J Clin Invest 1974; 54: 1337-43.
13. Rinehart JJ, Sagone AL, Balcerzak SP, Ackerman GA, LoBuglio AF. Effects of corticosteroid therapy on human monocyte function. N Engl J Med 1975; 292: 236-41.
14. Schaffner A. Therapeutic concentrations of glucocortcoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76: 1755-64. (Pubitemid 16196042)
15. Hamilton JA, Whitty GA, Royston AKM, Cebon J, Layton JE. Interleukin 4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes. Immunology 1992; 76: 566-71.
16. Diamond RD. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis 1983; 147: 160 (Letter). (Pubitemid 13190238)
17. Epstein SM, Verney E, Miale TD, Sidransky H. Studies on the pathogenesis of experimental pulmonary aspergillosis. Am J Pathol 1967; 51: 769-88.
18. Polak-Wyss A. Protective effect of human granulocyte colony-stimulating factor (G-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 1991; 34: 205-15.
19. Pan LY, Mendel DB, Zurlo J, Guyre PM. Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J Immunol 1990; 145: 267-75. (Pubitemid 20217411)
20. Abrahamsen TG, Carter CS, Read EJ, et al. Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reversed by storing the cells at 37 degrees C. J Clin Apheresis 1991; 6: 48-53.
21. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 61: 1185-93. (Pubitemid 23099183)
22. Roilides E, Mertins S, Eddy J, et al. Impairment of neutrophil chemotactìc and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J Pediatr 1990; 117: 53l-4.
23. Levitz SM, Diamond RD. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis 1985; 152: 938-15.
24. Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 1990; 162: 523-8. (Pubitemid 20239974)
25. Webel ML, Ritts RE, Taswell HF, Danadio JV, Woods JE. Cellular immunity after intravenous administration of methyl-prednisolone. J Lab Clin Med 1974; 83: 383-92.
26. Kasuya Y, Althaus JR, Freeman JP, Mitchum RK, Scelly JP. Quantitative determination of dexamethasone in human plasma by stable isotope dilution mass spectrometry. J Pharm Sci 1984; 73:446-51. (Pubitemid 14134315)
27. Smith PD, Lamerson CL, Banks SM, et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungcdal activity for Candida albicans. J. Infect Dis 1990; 161: 999-1005. (Pubitemid 20148340)
28. Reed SG, Nathan CF, Pihl DL, et al. Recombinant granulocyte-macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. J Exp Med 1987; 166: 1734-46. (Pubitemid 18000351)
29. Weiser WY, van Niel A, Clark SC, David JR, Remold HG. Recombinant human granulocyte-macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 1987; 166: 1436-46. (Pubitemid 18051433)
30. Nathan CF, Horowitz CD, de la Harpe J, et al. Administration of recombinant interferon-y to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc Nat Acad Sci USA 1985; 82: 8686-90. (Pubitemid 16101108)
31. Beaman L. Fungicidal activation of murine macrophages by recombinant gamma interferon. Infect Immun 1987; 55: 2951-5. (Pubitemid 18008263)
32. Wu-Hsieh B, Howard DH. Inhibition of intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun 1987; 55: 1014-6. (Pubitemid 17035443)
33. Brummer E, Morrison CJ, Stevens DA. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun 1985; 49: 724-30. (Pubitemid 15021536)
34. Flesch IEA, Schwamberger G, Kaufmann SHE. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol 1989; 142: 3219-24. (Pubitemid 19129946)
35. Brummer E, Hanson LH, Stevens DA. Kinetics and requirements for activation of macrophages for fungicidal activity: effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism. Cell Immunol 1991; 132: 236-45.
36. Roilides E, Holmes A, Blake C, et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-y. J Infect Dis 1994; 170: 894-9. (Pubitemid 24296569)
37. Cebon J, Dempsey P, Fox R, et al. Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay. Blood 1988; 72: 1340-7. (Pubitemid 18265902)
38. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992; 327: 28-35.
39. Shadduck RK, Waheed A, Evans C, Sulecki M, Rosenfeld CS. Serum and urinary levels of recombinant human granulocyte-macrophage colony-stimulating factor: assessment after intravenous infusion and subcutaneous infection. Exp Hemato! 1990; 18: 601 (Abstract).
40. Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp9l-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes. Blood 1992; 79: 735-44.
41. Ezekovitz RAB, Orkin SH, Newburger PE. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest 1987; 80: 1009-16. (Pubitemid 18075635)
42. Roth JA, Kaeberle ML. Effects of in vivo dexamethasone administration on in vitro bovine polymorphonuclear leukocyte function. Infect Immun 1981; 33: 434-41. (Pubitemid 11042651)